MedPath

PILOT STUDY TO ASSESS SAFETY AND TOLERABILITY OF LITHIUM ON SPINOCEREBELLAR ATAXIA OF TYPE 2 - Lithium in SCA2

Conditions
Spinocerebellar ataxia type 2
MedDRA version: 9.1Level: LLTClassification code 10031722
Registration Number
EUCTR2009-016317-20-IT
Lead Sponsor
IVERSITA` DEGLI STUDI DI NAPOLI FEDERICO II
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Authorised-recruitment may be ongoing or finished
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Molecular diagnosis of SCA2, age>18 years
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Heart disease
Liver disease
Thyroid dysfunction
Renal disease
Heart conduction abnormalities or abnormal ECG
Hyposodemia
Teatment with not allowed drugs
Acute diseases that might interfere with the study
Pregnancy or breastfeading

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath